Cargando…

Revisiting potential value of antitumor drugs in the treatment of COVID-19

Since an outbreak started in China in 2019, coronavirus disease 2019 (COVID-19) has rapidly become a worldwide epidemic with high contagiousness and caused mass mortalities of infected cases around the world. Currently, available treatments for COVID-19, including supportive care, respiratory suppor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Wenfang, Zeng, Zekun, Lin, Shumei, Hou, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526459/ https://www.ncbi.nlm.nih.gov/pubmed/36182930 http://dx.doi.org/10.1186/s13578-022-00899-z

Ejemplares similares

Revisiting the potential role of BCG and MMR vaccines in COVID-19
por: Bayram, Zeina, et al.
Publicado: (2022)

Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?
por: Pahan, Priyanka, et al.
Publicado: (2020)

Rapamycin golden jubilee and still the miraculous drug: a potent immunosuppressant, antitumor, rejuvenative agent, and potential contributor in COVID-19 treatment
por: Mohamed, Mohamed A., et al.
Publicado: (2022)

The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs
por: Son, Deok-Soo, et al.
Publicado: (2020)

Targeting cancer with sesterterpenoids: the new potential antitumor drugs
por: Zhang, Caiguo, et al.
Publicado: (2015)

COVID-19 and potential global mortality - Revisited
por: Grech, Victor
Publicado: (2020)

Antitumor Drugs and Their Targets
por: Dembic, Zlatko
Publicado: (2020)

Potential therapeutic value of necroptosis inhibitor for the treatment of COVID-19
por: Kang, Yongan, et al.
Publicado: (2022)

Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
por: Venditto, Vincent J., et al.
Publicado: (2021)

An Overview of Repurposed Drugs for Potential COVID-19 Treatment
por: Govender, Kamini, et al.
Publicado: (2022)

COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform
por: Ashraf, Muhammad Umer, et al.
Publicado: (2021)

Polysaccharides for the Delivery of Antitumor Drugs
por: Posocco, Bianca, et al.
Publicado: (2015)

Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies
por: Wang, Hong, et al.
Publicado: (2021)

Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits
por: Stella, Manuela, et al.
Publicado: (2023)

Revisiting the value of a statistical life: an international approach during COVID-19
por: Sweis, Nadia J.
Publicado: (2022)

Revisiting the therapeutic potential of tocotrienol
por: Ranasinghe, Ranmali, et al.
Publicado: (2022)

Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Q-valued functions revisited
por: Lellis, Camillo De, et al.
Publicado: (2011)

Comment on “Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?”
por: Cure, Erkan, et al.
Publicado: (2020)

Design, synthesis, and antitumor evaluation of histone deacetylase inhibitors with l-phenylglycine scaffold
por: Zhang, Yingjie, et al.
Publicado: (2015)

PD-L1 expression and tumor-infiltrating lymphocytes: Revisiting the antitumor immune response potential in breast cancer
por: Schalper, Kurt A
Publicado: (2014)

Revisiting Metchnikoff's work in light of the COVID-19 pandemic
por: Cavaillon, Jean-Marc, et al.
Publicado: (2022)

Potential Drugs and Remedies for the Treatment of COVID-19: a Critical Review
por: Barati, Fatemeh, et al.
Publicado: (2020)

Antitumor Potential of Marine and Freshwater Lectins
por: Catanzaro, Elena, et al.
Publicado: (2019)

Antitumor Potential of Immunomodulatory Natural Products
por: Nuzzo, Genoveffa, et al.
Publicado: (2022)

The potential value of blood monitoring of biologic drugs used in the treatment of rheumatoid arthritis
por: Perry, Martin, et al.
Publicado: (2020)

GPCRs Revisited: New Insights Lead to Novel Drugs
por: Eglen, Richard M., et al.
Publicado: (2011)

A review and revisit of nanoparticles for antimicrobial drug delivery
por: Liew, Kai Bin, et al.
Publicado: (2022)

Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas
por: Jeon, Jaewan, et al.
Publicado: (2021)

Revisiting Terminalia arjuna – An Ancient Cardiovascular Drug
por: Dwivedi, Shridhar, et al.
Publicado: (2014)

Marine Antitumor Drugs: Status, Shortfalls and Strategies
por: Bhatnagar, Ira, et al.
Publicado: (2010)

The "impact factor" revisited
por: Dong, Peng, et al.
Publicado: (2005)

Molnupiravir Revisited—Critical Assessment of Studies in Animal Models of COVID-19
por: Rasmussen, Henrik Berg, et al.
Publicado: (2023)

Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment
por: Witika, Bwalya A., et al.
Publicado: (2020)

A review of potential suggested drugs for coronavirus disease (COVID-19) treatment
por: Tarighi, Parastoo, et al.
Publicado: (2021)

Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment
por: Sahin, Gokben, et al.
Publicado: (2022)

Revisiting Oral Fluoroquinolone and Multivalent Cation Drug-Drug Interactions: Are They Still Relevant?
por: Pitman, Stuart K., et al.
Publicado: (2019)

New Approaches for Cancer Treatment: Antitumor Drugs Based on Gene-Targeted Nucleic Acids
por: Patutina, O.A., et al.
Publicado: (2009)

Curative Potential of High-Value Phytochemicals on COVID-19 Infection
por: Sruthi, Damodaran, et al.
Publicado: (2023)

Fibrates Revisited: Potential Role in Cardiovascular Risk Reduction
por: Kim, Nam Hoon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5pj1lcbohaq0mctb49pqp3re5m